Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Coinfection with all three viruses ramped up mortality risk nine times compared with having none of the viruses.
With the approval of Cyramza, there are now five targeted therapies for hepatocellular carcinoma.
Health care providers need to be on the lookout for muscle wasting in their patients with advanced liver disease, particularly when assessing...
More U.S. residents are now dying of hepatitis C complications than HIV-related illnesses, according to sobering data summarized in the...
People with liver cirrhosis may benefit from daily therapy with a blood thinner to prevent portal vein thrombosis (PVT), a potentially serious...
Three-year survival rates after a diagnosis of hepatocellular carcinoma (liver cancer) are similar between people living with HIV and HIV-nega...
Working with life expectancy calculations can be tricky.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.